The FDA proposed to make common prescription drugs, including those that treat diabetes, asthma and migraines, available over the counter in order to increase access to these medications. Proponents added the potential move could improve population health and proper medication use.
However, the AMA is taking a different stance, arguing the lack of physician involvement could lead to negative outcomes for patients. “Patients rely on physicians to provide sound diagnosis and treatment information and to help them meet their unique health needs” said Peter W. Carmel, MD, AMA president. “Expanding many prescription medications to OTC interferes with that important relationship without offering any real benefits to improve patients’ health or reduce their costs.”
Related Articles on Medication Safety:
Bill That Would Improve Drug, Medication Safety for Children Passes Senate Committee
CDC Issues Restatement on Single Dose, Single Use Vials
IOM Calls for Process to Improve Safety of Approved Drugs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
